In one of the most significant D2C acquisitions 2025 and major highlights in D2C news India, pharmaceutical major USV has signed a definitive agreement to acquire a 79% stake in Nutritionalab Private Limited, the parent company of Wellbeing Nutrition. The transaction values the Direct-to-consumer India nutraceutical brand at approximately ₹1,583 crore, marking a strong moment in India’s D2C ecosystem India and reinforcing the growing momentum in D2C industry news.
Founded in 2019, Wellbeing Nutrition has emerged as one of the fastest-growing D2C wellness startups within India’s evolving Direct-to-consumer India landscape. Operating in the nutraceutical segment, the brand offers a diversified portfolio of vitamins, minerals, protein blends, collagen, omega supplements, and other wellness-focused formulations. The company follows a robust omnichannel D2C strategy, selling through its own digital platform, online marketplaces, and offline retail channels, while also maintaining an international presence across the US, UK, and UAE. This expansion reflects broader D2C expansion plans seen across the D2C ecosystem India.
According to company disclosures, Wellbeing Nutrition reported revenue of around ₹170 crore in FY25, with a reported loss of approximately ₹30 crore. The brand has delivered 120% growth over the past two years and is targeting revenue of over ₹450 crore by FY27—an ambitious D2C revenue growth trajectory that places it among the latest D2C startups scaling rapidly in the premium D2C brands India category.
The acquisition is also a landmark event in D2C funding news and D2C startup valuation conversations. Data platform TheKredible indicates that Wellbeing Nutrition has raised close to $14 million to date, including a $10 million Series B funding India round led by Fireside Ventures and Hindustan Unilever (HUL) in December 2022. As part of this D2C exits India development, HUL will divest its entire 19.8% stake to USV for approximately ₹307 crore. HUL had invested around ₹70 crore, translating into more than a fourfold return on its original investment—an important data point in D2C investor insights and private equity in D2C narratives. Fireside Ventures and other early backers are also expected to partially dilute their holdings.
For USV, a six-decade-old pharmaceutical leader known for brands such as Glycomet GP, Ecosprin, and Roseday, this acquisition signals a strategic shift from prescription-led portfolios toward preventive and lifestyle-focused categories. By entering the D2C wellness startups segment, USV is participating directly in what’s happening in India’s D2C space today: the rapid rise of sustainable D2C brands and health-first consumer behavior India trends.
This move also comes amid a broader consolidation wave in D2C business India. Recently, Marico acquired a 60% stake in plant-based protein startup Cosmix at an equity valuation of ₹375 crore, while Hindustan Unilever Limited previously acquired skincare brand Minimalist at a pre-money valuation of ₹2,955 crore. These developments reflect an acceleration in D2C acquisitions 2025, signaling that legacy FMCG and pharmaceutical players increasingly view D2C brands India as strategic growth engines.
The Wellbeing Nutrition acquisition underscores a clear shift in D2C market trends 2025: larger corporations are backing high-growth, digital-first brands that combine science, consumer trust, and scalable supply chains. As India’s D2C ecosystem India continues to mature, such transactions highlight the long-term potential of nutraceutical and preventive wellness categories within the Direct-to-consumer startup IPO tracker and D2C brand acquisition tracker India narratives.
For the daily digest of D2C news in India, USV’s ₹1,583 crore valuation bet on Wellbeing Nutrition represents not just a transaction—but a defining chapter in India’s D2C business India evolution.
